#153245

Anti-CEACAM19 [Z5P2D9*A9]

Cat. #153245

Anti-CEACAM19 [Z5P2D9*A9]

Cat. #: 153245

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Carcinoembryonic Antigen Related Cell Adhesion Molecule 19

Class: Monoclonal

Application: ELISA ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CEACAM19 [Z5P2D9*A9]
  • Alternate name: CEACAM19, CEA related cell adhesion molecule 19, CEAL1
  • Clone: Z5P2D9*A9
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; WB
  • Description: CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer.
  • Immunogen: Peptide sequence RSINPARPLP (BLAST analysis revealed 100% identity with Gorilla)
  • Isotype: IgG
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: ELISA- Peptide immunogen, Western Blot- CEACAM19 overexpression lysates

Target Details

  • Target: Carcinoembryonic Antigen Related Cell Adhesion Molecule 19
  • Tissue cell line specificity: ELISA- Peptide immunogen, Western Blot- CEACAM19 overexpression lysates
  • Target background: CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer.

Applications

  • Application: ELISA ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C